About ViroPharma
ViroPharma is a company based in Exton (United States) founded in 1994 was acquired by Shire in November 2013. ViroPharma has completed 1 acquisition, including DuoCort Pharma. ViroPharma offers products and services including Oncology Medicines, Rare Disease Drugs, and Vaccine Products.
- Headquarter Exton, United States
- SectorsHealthcare
- Website viropharma.com
- Social LinkedIn
- Acquired by Shire (Nov 2013)
- Legal Name Takeda Pharmaceutical Company Limited
- Investors
- Investments & Acquisitions
- Acquired byShire
(Nov 2013)
Products & Services of ViroPharma
ViroPharma offers a comprehensive portfolio of products and services, including Oncology Medicines, Rare Disease Drugs, and Vaccine Products.
Treatments targeting cancer through innovative drug development
Medications for genetic and chronic rare disorders
Solutions for infectious diseases and global health needs
Investors in ViroPharma
ViroPharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Takeda Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Rare disease treatments are developed by a specialty biopharmaceutical firm. | 1986 | shire.com | Dublin, Ireland |
Investor details for ViroPharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ViroPharma
6 people are tracked at ViroPharma (1 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Vincent J. Milano | Chief Executive Officer | Leadership |
Nicolette Relkin | Electrical Apprentice | Team |
Chantal Haskins | Pharmaceutical Specialist | Team |
Gerald Patton | Manufacturing/ Production | Team |
Patrick Scoble | Manager Medical Affairs | Team |
Linda Attore | Executive Assistant | Team |
Complete people profiles for ViroPharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ViroPharma
ViroPharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include DuoCort Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Improved glucocorticoid replacement therapy for adrenal insufficiency is developed. | duocort.com | Helsingborg, Sweden | 2004 | Oct 2011 | $33.1M |
Complete acquisition details for ViroPharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of ViroPharma
3 dated milestones of ViroPharma across 19 years, from founding to its latest funding, stage changes and deals.
- Founded ViroPharma is founded.
- Acquisition Acquires DuoCort Pharma.
- Exit Acquired by Shire.
Web traffic of ViroPharma
Websites that share an audience with ViroPharma (viropharma.com).
Websites whose visitors overlap most with ViroPharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ventanamed.com | 100% | – | – | View details | |
mundipharma.net | mundipharma.net | 100% | – | – | – |
| cap-m-quik.com | 100% | – | – | View details | |
quigleyco.com | quigleyco.com | 100% | – | – | – |
| globequimica.com.br | 100% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 32 similar websites and full traffic analytics for ViroPharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 32 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to ViroPharma
10 companies that operate in the same segment as ViroPharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ViroPharma
ViroPharma was founded in 1994.
ViroPharma is headquartered in Exton, United States. It is registered at Exton, Pennsylvania, United States.
ViroPharma was focussed on developing a portfolio of therapeutics for rare and Orphan diseases including C1-esterase inhibitor deficiency, cytomegalovirus (CMV), Friedreichs Ataxia, eosinophilic esophagitis (EoE) and adrenal insufficiency. Its commercial product Cinryze, a C1-esterase inhibitor is approved by the FDA for routine prophylaxis against angioedema attacks in adolescent and adult patients with HAE. In November 2013, Shire acquired Viropharma for 4.2B.
ViroPharma offers Oncology Medicines, Rare Disease Drugs, and Vaccine Products.
ViroPharma has made 1 acquisition, including DuoCort Pharma.
ViroPharma has 1 investor. Key investors include Takeda Pharmaceuticals.
ViroPharma operates through Takeda Pharmaceutical Company Limited.
Yes. ViroPharma was acquired by Shire in November 2013.